Simplification to co-formulated rilpivirine/emtricitabine/tenofovir in virologically suppressed patients: Data from a multicenter cohort

C Pinnetti; Simona Di Giambenedetto; F Maggiolo; P Lorenzini; M Fabbiani; C Tommasi; A Latini; A Ammassari; L Loiacono; G Sterrantino; R Bellagamba; E Boumis; A Antinori; M. Zaccarelli

doi:10.7448/IAS.17.4.19812

Simplification to co-formulated rilpivirine/emtricitabine/tenofovir in virologically suppressed patients: Data from a multicenter cohort

C Pinnetti, Simona Di Giambenedetto, F Maggiolo, P Lorenzini, M Fabbiani, C Tommasi, A Latini, A Ammassari, L Loiacono, G Sterrantino, R Bellagamba, E Boumis, A Antinori, M. Zaccarelli

Research output: Contribution to journal › Conference article › peer-review

Abstract

To assess efficacy and safety of treatment simplification to co-formulated Rilpivirine/Emtricitabine/Tenofovir (RPV/FTC/TDF) in virologically suppressed patients.

Original language	English
Pages (from-to)	19812-19812
Number of pages	1
Journal	Journal of the International AIDS Society
Volume	17
DOIs	https://doi.org/10.7448/IAS.17.4.19812
Publication status	Published - 2014
Event	HIV Drug Therapy Glasgow Congress 2014 - Glasgow Duration: 2 Nov 2014 → 6 Nov 2014

Keywords

HIV
simplification
therapy

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.7448/IAS.17.4.19812

Cite this

Pinnetti, C., Di Giambenedetto, S., Maggiolo, F., Lorenzini, P., Fabbiani, M., Tommasi, C., Latini, A., Ammassari, A., Loiacono, L., Sterrantino, G., Bellagamba, R., Boumis, E., Antinori, A., & Zaccarelli, M. (2014). Simplification to co-formulated rilpivirine/emtricitabine/tenofovir in virologically suppressed patients: Data from a multicenter cohort. Journal of the International AIDS Society, 17, 19812-19812. https://doi.org/10.7448/IAS.17.4.19812

@article{f65c8b1468454ab892fe0e02f7e4d07b,

title = "Simplification to co-formulated rilpivirine/emtricitabine/tenofovir in virologically suppressed patients: Data from a multicenter cohort",

abstract = "To assess efficacy and safety of treatment simplification to co-formulated Rilpivirine/Emtricitabine/Tenofovir (RPV/FTC/TDF) in virologically suppressed patients.",

keywords = "HIV, simplification, therapy, HIV, simplification, therapy",

author = "C Pinnetti and {Di Giambenedetto}, Simona and F Maggiolo and P Lorenzini and M Fabbiani and C Tommasi and A Latini and A Ammassari and L Loiacono and G Sterrantino and R Bellagamba and E Boumis and A Antinori and M. Zaccarelli",

year = "2014",

doi = "10.7448/IAS.17.4.19812",

language = "English",

volume = "17",

pages = "19812--19812",

journal = "Journal of the International AIDS Society",

issn = "1758-2652",

publisher = "John Wiley & Sons Inc.",

note = "HIV Drug Therapy Glasgow Congress 2014 ; Conference date: 02-11-2014 Through 06-11-2014",

}

Pinnetti, C, Di Giambenedetto, S, Maggiolo, F, Lorenzini, P, Fabbiani, M, Tommasi, C, Latini, A, Ammassari, A, Loiacono, L, Sterrantino, G, Bellagamba, R, Boumis, E, Antinori, A & Zaccarelli, M 2014, 'Simplification to co-formulated rilpivirine/emtricitabine/tenofovir in virologically suppressed patients: Data from a multicenter cohort', Journal of the International AIDS Society, vol. 17, pp. 19812-19812. https://doi.org/10.7448/IAS.17.4.19812

TY - JOUR

T1 - Simplification to co-formulated rilpivirine/emtricitabine/tenofovir in virologically suppressed patients: Data from a multicenter cohort

AU - Pinnetti, C

AU - Di Giambenedetto, Simona

AU - Maggiolo, F

AU - Lorenzini, P

AU - Fabbiani, M

AU - Tommasi, C

AU - Latini, A

AU - Ammassari, A

AU - Loiacono, L

AU - Sterrantino, G

AU - Bellagamba, R

AU - Boumis, E

AU - Antinori, A

AU - Zaccarelli, M.

PY - 2014

Y1 - 2014

N2 - To assess efficacy and safety of treatment simplification to co-formulated Rilpivirine/Emtricitabine/Tenofovir (RPV/FTC/TDF) in virologically suppressed patients.

AB - To assess efficacy and safety of treatment simplification to co-formulated Rilpivirine/Emtricitabine/Tenofovir (RPV/FTC/TDF) in virologically suppressed patients.

KW - HIV

KW - simplification

KW - therapy

KW - HIV

KW - simplification

KW - therapy

UR - http://hdl.handle.net/10807/61293

U2 - 10.7448/IAS.17.4.19812

DO - 10.7448/IAS.17.4.19812

M3 - Conference article

SN - 1758-2652

VL - 17

SP - 19812

EP - 19812

JO - Journal of the International AIDS Society

JF - Journal of the International AIDS Society

T2 - HIV Drug Therapy Glasgow Congress 2014

Y2 - 2 November 2014 through 6 November 2014

ER -

Simplification to co-formulated rilpivirine/emtricitabine/tenofovir in virologically suppressed patients: Data from a multicenter cohort

Abstract

Keywords

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this